Related Experiment Video
Updated: May 29, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
Tonsillectomy combined with steroid pulse therapy induces clinical remission of IgA nephropathy
Hiroyuki Komatsu1, Shouichi Fujimoto
1First Department of Internal Medicine, University of Miyazaki Hospital, Miyazaki, Japan. hkomatsu@fc.miyazaki-u.ac.jp
Abstract:
Tonsillectomy combined with steroid pulse therapy has been a popular approach to treating IgA nephropathy (IgAN) in Japan for several years. However, little is understood about how such combined therapy affects the clinical course of IgAN. We therefore compared the effects of the combined therapy with those of steroid pulsing alone in a controlled study of patients with IgAN. The achievement ratio of clinical remission (CR), defined as the disappearance of urinary protein (UP) and occult blood (UOB), were compared between tonsillectomy combined with steroid pulse therapy (n=35) and steroid pulse monotherapy (n=20). The CR rate was higher in the group given combined therapy than that given monotherapy at the final observation 54.0±21.2 months after the initial treatment (54.3 vs. 25.0%, p=0.033). The Cox regression model showed that the combined therapy caused UP to disappear 6-fold more effectively than monotherapy. These findings suggest that tonsillectomy combined with steroid pulse therapy induces CR in patients with IgAN. Meanwhile, the indications for this therapy and verification of its positive longterm prognosis require urgent validation.
More Related Videos
08:43Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
Published on: January 31, 2020
08:44Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
Published on: May 19, 2026
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Chronic Kidney Disease III: Interprofessional Care
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Acute Pyelonephritis II: Diagnostic Studies and Management